Literature DB >> 7075126

Obesity, sex, and acetaminophen disposition.

D R Abernethy, M Divoll, D J Greenblatt, B Ameer.   

Abstract

Twenty-one obese (14 women; 7 men) and 21 normal (11 women; 10 men) drug-free and age-matched subjects were given single 650-mg IV doses of acetaminophen. Mean total body weights (TBW) for the groups were as follows: obese men, 134.9 kg; control men 70.6 kg; obese women, 87.9 kg; and control women, 55.0 kg; ideal body weight (IBW) was similar for all of the groups. Acetaminophen elimination half-life (t1/2 beta) did not differ among groups. Absolute volume of distribution (Vd) was greater in obese than in control men (109 and 77 l, P less than 0.05) and greater in control men than in control women (77 and 52 l, P less than 0.05), but Vd corrected for TBW was smaller in obese than in control men (0.81 and 1.09 l/kg TBW, P less than 0.05) and smaller in obese than control women (0.71 and 0.95 l/kg TBW, P less than 0.05). Absolute metabolic clearance was greater in obese than in control men (484 and 323 ml/min, P less than 0.05), in obese than in control women (312 and 227 ml/min, P less than 0.05), and in control men than women (323 and 227 ml/min, P less than 0.05). After correction for TBW, however, clearance between control and obese subjects of the same sex did not differ. Acetaminophen Vd is increased in obesity and in men relative to women, but the drug's distribution into body weight exceeding IBW is less extensive than that into IBW. For men the distribution ratio is 0.44 and for women, 0.31. Acetaminophen clearance increases with body weight and therefore is much greater in obese patients and in men.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075126     DOI: 10.1038/clpt.1982.111

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  25 in total

Review 1.  Altered drug disposition following bariatric surgery: a research challenge.

Authors:  H Karl Greenblatt; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2015-06       Impact factor: 6.447

Review 2.  Impact of obesity on drug metabolism and elimination in adults and children.

Authors:  Margreke J E Brill; Jeroen Diepstraten; Anne van Rongen; Simone van Kralingen; John N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2012-05-01       Impact factor: 6.447

3.  Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.

Authors:  Michael H Court; Zhaohui Zhu; Gina Masse; Su X Duan; Laura P James; Jerold S Harmatz; David J Greenblatt
Journal:  J Pharmacol Exp Ther       Date:  2017-06-29       Impact factor: 4.030

Review 4.  A Review of the Toxicologic Implications of Obesity.

Authors:  Matthew Zuckerman; Howard A Greller; Kavita M Babu
Journal:  J Med Toxicol       Date:  2015-09

5.  Effect of two antacids on the bioavailability of paracetamol.

Authors:  H Albin; F Demotes-Mainard; G Vinçon; A Bedjaoui; B Begaud
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism.

Authors:  Albert Goday Arno; Magí Farré; Jose Rodríguez-Morató; Jose M Ramon; Clara Pérez-Mañá; Esther Papaseit; Ester Civit; Klaus Langohr; Marcel Lí Carbó; David Benaiges Boix; Olga Castañer Nino; Juana Antonia Flores Le Roux; Manuel Pera; Luis Grande; Rafael de la Torre
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

Review 7.  Drug disposition in obese humans. An update.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

8.  Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients.

Authors:  L A Bauer; W A Edwards; E P Dellinger; D A Simonowitz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam.

Authors:  D R Abernethy; D J Greenblatt; M Divoll; R B Smith; R I Shader
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 10.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.